These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630 [No Abstract] [Full Text] [Related]
4. The treatment of chronic anal fissure with botulinum toxin. Godevenos D; Pikoulis E; Pavlakis E; Daskalakis P; Stathoulopoulos A; Gavrielatou E; Leppäniemi A Acta Chir Belg; 2004 Oct; 104(5):577-80. PubMed ID: 15571027 [TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin or lateral sphincterotomy for the treatment of chronic anal fissure?]. Aires FT; Soares RP; Bernardo WM; Araujo SE Rev Assoc Med Bras (1992); 2009; 55(4):369. PubMed ID: 19750297 [No Abstract] [Full Text] [Related]
6. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months. Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408 [No Abstract] [Full Text] [Related]
7. Toxins 99, new information about the botulinum neurotoxins. Carruthers A; Carruthers J Dermatol Surg; 2000 Mar; 26(3):174-6. PubMed ID: 10759788 [No Abstract] [Full Text] [Related]
8. Botox and Dysport are distinct. Madaliński M Endoscopy; 2000 Jun; 32(6):502-3. PubMed ID: 10863924 [No Abstract] [Full Text] [Related]
9. Botulinum toxin and anal fissure: efficacy and safety systematic review. Yiannakopoulou E Int J Colorectal Dis; 2012 Jan; 27(1):1-9. PubMed ID: 21822595 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A in anal fissure: why does it work? Jost WH; Aoki KR Dis Colon Rectum; 2004 Feb; 47(2):257-8. PubMed ID: 15043302 [No Abstract] [Full Text] [Related]
11. Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis. Baumann LS; Halem ML Arch Dermatol; 2003 Feb; 139(2):226-7. PubMed ID: 12588237 [No Abstract] [Full Text] [Related]
12. Treatment with botulinum toxin in children with chronic anal fissure. Husberg B; Malmborg P; Strigård K Eur J Pediatr Surg; 2009 Oct; 19(5):290-2. PubMed ID: 19746337 [TBL] [Abstract][Full Text] [Related]
13. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study. Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products. Dessy LA; Fallico N; Mazzocchi M; Scuderi N Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763 [TBL] [Abstract][Full Text] [Related]
15. [Manometric factors associated with recurrence in botulinum toxin treatment for chronic anal fissure]. Arroyo A; Pérez-Vicente F; Miranda E; Serrano P; Pérez-Vázquez M; Calpena R Gastroenterol Hepatol; 2005; 28(6):311-4. PubMed ID: 15989810 [TBL] [Abstract][Full Text] [Related]
17. New botulinum toxin approved with REMS. Thompson CA Am J Health Syst Pharm; 2010 Sep; 67(18):1486. PubMed ID: 20811019 [No Abstract] [Full Text] [Related]
18. Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications. de Almeida AT; De Boulle K J Cosmet Laser Ther; 2007; 9 Suppl 1():17-22. PubMed ID: 17885882 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of anal fissures with botulinum toxin]. Wollina U Zentralbl Chir; 2008 Apr; 133(2):123-8. PubMed ID: 18415898 [TBL] [Abstract][Full Text] [Related]
20. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia. Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]